a r t i c l e s of B-cell ontogeny, approximations of the unmutated common ancestor (UCA) have been inferred for V1V2-directed bNAb lineages from donors CH0219 and CAP256 (refs. 15,16) , which have indicated that the long anionic CDR H3 is a product of recombination 15, 16 . Initial recognition of UCA (or of V gene-reverted approximations) appears to be restricted to select strains of HIV-1 (for example, CAP256-SU or ZM233) 15, 16, 20 , to use similar D genes and in some cases related V genes, and to contain similar motifs (for example, YYD) in the CDR H3 (refs. 15-18) . Despite this extensive commonality, it has been unclear whether these bNAbs recognize HIV-1 Env through a common molecular mechanism.
The only atomic-level information on the interactions of these V1V2-directed bNAbs with HIV-1 Env derives from scaffolded V1V2 structures of antibodies PG9 and PG16 from donor IAVI 24, in which the CDR H3 penetrates and thus interacts in a parallel intermolecular strand association with strand C of V1V2, and N-glycans from residues 160 and 156 (or 173) are recognized by the heavy and light chains of the antibody 22, 26 . The combination of this atomic-level information and negative-stain EM of PG9 in complex with a soluble trimeric Env mimic, BG505 SOSIP.664 (ref. 27) , suggest that the quaternary dependency of PG9 arises from its recognition of glycan N160 from a neighboring protomer 24 .
The absence of atomic-level information on the recognition of V1V2-directed bNAbs from other donors raises a number of questions. Do V1V2-directed bNAbs from the other donors use a similar strand-strand association in their recognition? What is the basis of their quaternary specificity: does it arise from glycan recognition, as it does with PG9? And if the molecular features of V1V2-directed bNAbs were indeed similar, how would one devise a common set of immunogens to facilitate their development? Here, we set out not only to provide an atomic-level understanding of V1V2-directed bNAb recognition in another donor but also to use this information in the design of class-specific antigens. To facilitate crystallization, we designed trimeric V1V2 scaffolds capable of interacting with quaternary-specific V1V2-directed bNAbs, and we determined cocrystal structures with the antigen-binding fragments (Fabs) of bNAbs CH03 and CH04, both from donor CH0219. We used hydrogen-deuterium exchange (HDX) and arginine scanning to delineate Env-interactive regions of bNAb CAP256-VRC26.03 from donor CAP256 and to model its interaction with V1V2. Finally, we used neutralization screening with UCA and intermediates of V1V2-directed bNAbs to engineer antigens capable of interacting with developmental intermediates. Altogether, the structural similarities in antibody recognition along with ontogeny similarities (and differences) in development indicate that the V1V2-directed bNAbs form an extended class, which we define as antibodies that do not necessarily share genetic commonalities but nonetheless display a characteristic mode of antigen interaction. Extended-class immunogens-such as the soluble chimeric trimers developed here through a neutralizationand ontogeny-based chimera strategy-may provide a general means for eliciting bNAbs against specific sites of Env vulnerability.
RESULTS

Design and crystallization of trimeric scaffolded V1V2s
To obtain a cocrystal structure of HIV-1 Env with a V1V2-directed bNAb from an additional donor, we first screened the V1V2 scaffolds from PDB 1FD6 (ref. 28 ) and PDB 1JO8 (ref. 29) , which are recognized by bNAbs PG9 and PG16 from donor IAVI 24 and have previously been used in the structural analyses of these antibodies 22, 25 . bNAbs CH01-04, CAP256-VRC26.01-12 and PGT141-145 did not bind these monomeric V1V2 scaffolds. One possible explanation for this lack of recognition might be related to the quaternary dependence of bNAbs CH01-04, CAP256-VRC26.01-12 and PGT141-145, which is more stringent than that of antibody PG9. To accommodate their quaternary dependencies, we designed a library of scaffolded V1V2s based on trimeric scaffolds, expressed secreted versions of these scaffolds in a 96-well format [30] [31] [32] and assessed PGT145 recognition directly from expressed supernatant ( Fig. 1a and Supplementary Fig. 1a,b) . We chose PGT145 for its high quaternary specificity and its broad and potent neutralization; it recognized V1V2 chimeras from two trimeric scaffolds, PDB 1VH8 (ref. 33 ) and PDB 4F2K 34 .
A PDB 1VH8-scaffolded V1V2 showed strong binding, and three PDB 4F2K-scaffolded V1V2s with differing linker lengths showed moderate binding to PGT145 (Supplementary Fig. 1b,c) . We expressed and purified these trimeric scaffolded V1V2s in GnTI − cells and assessed binding by surface plasmon resonance, which revealed strong to moderate binding for PG9 (K d 24-500 nM) and weak binding for other V1V2-targeting bNAbs such as CH01 Fig. 1d ). We further optimized these scaffolded V1V2s by varying the HIV-1 strain and linker connections. Optimized PDB 1VH8 trimeric scaffolds with V1V2 from HIV-1 strains CAP256-SU or A244 (also known as CM244, which was neutralized well by CH01-04 (ref. 15)) crystallized with the Fabs of bNAbs CH03 or CH04, respectively (Supplementary Fig. 1e ).
Structures of scaffolded V1V2 with antibodies CH03 and CH04
We solved the crystal structure of Fab CH03 in complex with the scaffolded V1V2 from HIV-1 strain CAP256-SU by molecular replacement with the previously determined Fab CH04 structure 22 (Table 1) . Overall, the structure revealed that CH03 inserts a protruding CDR H3, which is bent to recognize strand C of V1V2 in a parallel strand-strand interaction (Fig. 1b) .
The scaffolded V1V2 formed a five-stranded β-barrel similar to that of V1V2 in its prefusion closed Env conformation 35 and to that of V1V2 in complex with antibody 830A 36 . This five-stranded β-barrel differs slightly from the four-stranded Greek key motif observed in the scaffolded V1V2s bound by PG9 (ref. 22 ) and by PG16 (ref. 25) , in which the scaffolded V1V2 dimerized at a lattice contact, thus inhibiting the formation of strand C′. Overall, superposition of V1V2s from scaffolded and Env contexts showed high structural similarity, with an r.m.s. deviation of 1.1 Å for 45 β-strand residues (Fig. 1c) .
Analysis of the interface between Fab CH03 and scaffolded V1V2 revealed that N-glycan interactions dominated: 1,592 Å 2 of the CH03 interactive surface was buried by N-linked glycan (82% of the CH03 interface), with protein interactions accounting for only 384 Å 2 (19% of the CH03 interface) (Fig. 2) . We observed electron density for four N-linked glycans emanating from residues N130, N156 and N160 of one V1V2 and from residue N139 of a neighboring V1V2 (Fig. 2a,b) . Over a third of the CH03-glycan interactions occurred with the two proteinproximal N-acetylglucosamines at the base of each N-linked glycan; these totaled nine hydrogen-bonding interactions and 741 Å 2 of buried surface (Fig. 2c) . For glycan N130, we observed density for four mannose residues, three of which contacted the CH03 heavy chain. Glycan N156 also interacted with the CH03 heavy chain, but we observed no density beyond the protein-proximal N-acetylglucosamines. For glycan N160, we observed density for five mannose residues, of which four were involved with the CH03 heavy chain, and a fifth interacted with the CH03 heavy chain-light chain interface. Glycan N139 of the neighboring protomer showed clear density for five mannose residues and had the most substantial CH03 interactions, comprising 14 hydrogen Values in parentheses are for highest-resolution shell. One crystal was used to measure the data for each complex. a r t i c l e s bonds and 729 Å 2 of buried surface. Four of the N139 mannose residues interacted with the light chain; a fifth was extensively buried at the heavy chain-light chain interface, with six hydrogen bonds and 204 Å 2 of buried surface.
In addition to the glycan interactions, parallel strand-strand interactions occurred between a hairpin in the CH03 CDR H3 and strand C of V1V2 (Fig. 2e) . Other than the four strand-strand hydrogen bonds, most of the protein-protein interactions were hydrophobic in nature. Ile100E and Tyr100G (Kabat notation) in the CDR H3 stack over the V1V2-strand C backbone and aliphatic portions of the side chains (Fig. 2f,g ). A salt bridge between Glu30 in the CDR H1 of CH03 and Lys171 of V1V2 provided the only notable electrostatic interaction.
We also obtained cocrystals of Fab CH04 in complex with a PDB 1VH8-scaffolded V1V2 from HIV-1 strain A244 and solved the structure of the complex ( Table 1) . Overall, the CH04-V1V2 structure showed a similar glycan-dominated interface as that of CH03-V1V2, and CH04 also inserted a CDR H3 hairpin to recognize strand C of V1V2 in a parallel strand-strand manner (Supplementary Fig. 2 ).
Quaternary recognition of glycan in scaffold and Env contexts
Because CH03 showed extensive contacts with glycan N139 on a neighboring protomer, yet this glycan had not been previously implicated in CH03 interaction, we investigated quaternary scaffold interactions further. Although the V1V2 domain in the trimeric scaffold and trimeric Env aligned well as individual domains (Fig. 1c) , they showed substantially different trimeric arrangements (Fig. 3a,b) . Indeed, alignment of a single V1V2 domain from scaffold and Env contexts would position the trimeric counterparts in mostly nonoverlapping locations (Fig. 3c) .
We observed that glycan N139 on the neighboring V1V2 in the trimeric scaffold was positioned similarly to glycan N160 on the neighboring V1V2 in trimeric Env (Fig. 3d,e) . Notably, the protein-proximal N-acetylglucosamines emanating from N139 (scaffold context) and N160 (Env context) were positioned to within 3.5 Å. This suggests that in the trimeric Env context, CH03 would be able to recognize glycan N160 on a neighboring V1V2 in a manner similar to its recognition of N139 in the scaffold context (Fig. 3f,g ). In the scaffold context, these CH03 interactions would be symmetric and would lead to three CH03s, each interacting in a similar way with four glycans. However, in the Env context, the interactions were not compatible with binding of three Fabs, and only a single CH03 Fab would be able to interact with each Env trimer (Fig. 3d,e) .
Modeled interaction between antibody CAP256-VRC26 and V1V2
Similarly to the quaternary interaction proposed for CH03 and observed with IAVI 24, V1V2-directed antibodies from both donor CAP256 and donor IAVI 84 also showed a single Fab recognizing V1V2 at the trimer apex 16, 19 . However, despite substantial effort, we were unable to produce cocrystals for any of the broadly neutralizing antibodies from donors CAP256 or IAVI 84 with V1V2. Modeling of the Fab PGDM1400 structure from donor IAVI 84, which displays a straight extended CDR H3, into a similar orientation as that seen in the negative-stained two-dimensional (2D) class-average EM density of the Fab-Env trimer (PDB 4RQQ 19 ) indicated that PGDM1400 CDR H3 may assume a different structure, because the extended CDR H3 observed in the ligand-free Fab crystal structure (stabilized by a strand-strand antiparallel lattice interaction in the ligand-free Fab context) would otherwise clash. Modeling of the CAP256-VRC26 structures from donor CAP256 (ref. 16 ), which display bent CDR H3s that are more axe-like than hammerhead-like, into the negativestain EM density 16 , indicated a possible strand-strand interaction Fig. 3 ).
To provide additional experimental constraints, we analyzed rates of HDX from CAP256-VRC26.03 either free of ligand or bound to the BG505 SOSIP.664 Env trimer (Fig. 4a) ; we used CAP256-VRC26.03 because this was the only structure with structural definition of the entire CDR H3 (ref. 16 ). HDX information from four overlapping peptides pinpointed reduced HDX rates to a seven-residue stretch in the CDR H3; on Env, the HDX information pinpointed a short peptide in the strand-C region of V1V2 (Supplementary Fig. 3b) . Interestingly, the peptides bearing double tyrosine sulfation appeared to become substantially more protected upon binding, thus suggesting that the doubly sulfated Fab may form a more stable complex with the epitope than does the singly sulfated variant (Fig. 4a) . We also used an arginine-scanning approach 22 to map the CAP256-VRC26.03 paratope ( Supplementary Fig. 3c) ; arginine scanning disrupts interactions through steric interference, thus allowing for a more robust delineation of contacts than can be achieved through alanine scanning. This paratope mapping implicated the CDR H3 as the primary means of Env contact (Fig. 4b) .
We combined constraints from Fab-Env negative stain, from HDX and from arginine scanning to model the CAP256-VRC26 interaction with V1V2 in the context of the BG505 SOSIP.664 trimer (Fig. 4c) . We used the CAP256-VRC26.09 antibody for this modeling because this antibody showed high affinity for the SOSIP trimer, and the negativestain EM map with the SOSIP.664 trimer had been obtained with this antibody. This model suggested a strand-strand interaction, occurring in an antiparallel manner, between the seven residues of the CDR H3 implicated by HDX and strand C of V1V2 (Fig. 4d) . Tryptophan side chains could stack against the strand-C backbone, and electrostatic interactions were facilitated by two sulfated tyrosine and two aspartate residues; because of the greater distance between strand-strand interactions and other CDR regions, interactions with N-linked glycan would be expected to occur with the mannose branches to a greater extent than with the N-acetylglucosamine stalks.
A common mode of V1V2 recognition by antibody
The cocrystal structures of V1V2 with CH03 and CH04 from donor CH0219 and the modeled interaction of V1V2 with CAP256-VRC26 from donor CAP256 provide atomic-level insight into V1V2-directed bNAbs from two donors, and we integrated this information into the previously published characterization of V1V2 with PG9 and PG16 from donor IAVI 24 ( Fig. 4e-g ). In all three donors, a strand-strand interaction was implicated between an extended CDR H3 on the antibody and the C strand of V1V2. With bNAbs from donors CH0219 and IAVI 24, the interaction involved parallel hydrogen-bonding, whereas in donor CAP256, the interaction involved antiparallel hydrogenbonding. In terms of CDR H3 side chain interactions, bNAbs from CH0219 used primarily hydrophobic interactions, those from IAVI 24 primarily used electrostatic interactions, and those from CAP256 used a mixture of hydrophobic and electrostatic interactions.
bNAbs from all three donors bound a single Fab per trimer (Supplementary Fig. 4 ). For bNAbs from CH0219, the crystal-structure data indicated this stoichiometry and the known quaternary specificity to derive from recognition of N-linked glycans that emanate from neighboring V1V2s. For bNAbs from IAVI 84, the published structural data 22, 24, 25 have also indicated quaternary recognition of N160. For bNAbs from CAP256, modeling indicated protein-protein interactions to occur mostly within a single V1V2 protomer; however the model implicated electrostatic interactions with each of the neighboring protomers, thus suggesting that the CAP256-VRC26 bNAb lineage has strong quaternary specificity that derives from quaternary recognition of glycan and protein ( Supplementary Fig. 4 ). Minor differences in the precise engagement of the glycans between IAVI 24 and CH0219 may result in varying tolerances to different glycoforms present on the HIV-1 Env, as has been seen with V3 N332-directed lineages.
We observed some CDR H3 features, such as an enrichment of aspartate and tyrosine residues in the CDR H3s of all of the V1V2-directed antibodies. These appeared to have diverse roles. For example, a D gene-encoded YYD motif occurred in the CDR H3s of both PG9 and CAP256-VRC26.09, and in both antibodies both tyrosines were sulfated. However, in PG9, the sulfated YYD tyrosines interact with strand-C side chains; in contrast, in the CAP256-VRC26.09 model, the sulfated YYD tyrosines appeared to interact with a neighboring protomer (Supplementary Fig. 4 ). The conservation of the YYD motif in spite of its different roles may relate to the preferred anionic character of the paratope 16, 22 , in which the YYD motif would 
a b c npg a r t i c l e s potentially bear three negative charges if the tyrosines were sulfated as in PG9 and CAP256-VRC26.09. In addition, the preferred use of specific D and J genes, such as D3-3, which contains the YYD motif, is associated with long CDR H3s 37, 38 . Overall, although there were substantial differences between the V1V2-directed antibodies, the similarities observed in strand-strand protein recognition and quaternary recognition of glycan suggested a common mode of V1V2 recognition by bNAbs from donors CH0219, CAP256 and IAVI 24.
Ontogenies of V1V2-directed antibodies
The finding of a common mode of V1V2 recognition, shared by bNAbs from multiple donors in the absence of a common genetic origin, suggested an extended class, which we define as antibodies lacking specific genetic commonalities but nonetheless using a characteristic mode of antigen interaction. We further investigated the development of these V1V2-directed bNAbs to determine whether similarities in molecular recognition might extend to similarities in B-cell ontogeny. In particular, we sought to understand how the structural characteristics of the V1V2-directed bNAbs such as long anionic CDR H3s-which are needed to penetrate the glycan shield and interact with the exposed cationic strand C in V1V2-are created by B-cell processes of recombination and somatic hypermutation and whether these processes are similar from donor to donor.
To enhance the lineage information of V1V2-directed bNAbs from donor CH0219, we used both paired and unpaired heavy chainlight chain sequencing to obtain sequences of additional lineage members. The new sequences were most similar to antibody CH01 (Supplementary Fig. 5 ). The earliest well-defined maximum-likelihood intermediate had 0.3% nucleotide-level somatic hypermutation, a CDR H3 of 24 amino acids and a net −4 charge (Fig. 5a) . Analysis of glycan-interacting residues indicated that 71% did not require somatic hypermutation (SHM) in intermediate I ( Supplementary  Fig. 5) . Altogether, the lineage information indicated that the long CDR H3 derives from recombination, and residues involved in glycan recognition are partially present in the initial recombinant and evolve upon maturation.
The CAP256-VRC26 bNAb lineage, previously substantially defined by longitudinal sampling 16 , also indicated that the long CDR H3 is result of recombination (Fig. 5a) . For the PG9-bNAb lineage from IAVI 24, which has been defined with only two members, PG9 and PG16, we also carried out maximum-likelihood analysis. The earliest intermediate had 4.4% nucleotide-level SHM, a CDR H3 of 28 amino acids and a net −3 charge (Fig. 5a) . Analysis of glycan-interacting residues indicated that 43% were present in the earliest intermediate (Supplementary Fig. 6 ).
We also analyzed the PGT145-bNAb lineage from donor IAVI 84 (Supplementary Fig. 5 ). Although the likely conformational change in CDR H3 between free and bound conformations made modeling difficult, many features of PGT145-lineage antibodies were common with those of V1V2-directed bNAbs from CH0219, CAP256 and IAVI 24, thus suggesting a similar mode of recognition. To the PGT141-145 and PGDM1400-1412 series of bNAbs 18, 19 , we used 'intradonor' phylogenetic analysis to add sequences of antibodies from previously published next-generation sequencing of donor IAVI 84 B-cell transcripts 39 . The earliest well-defined maximum-likelihood intermediate had 6.1% nucleotide-level somatic hypermutation, a CDR H3 of 32 amino acids and a net −5 charge (Fig. 5a) .
To determine which class features might provide roadblocks for development, we analyzed the prevalence of antibodies with long anionic CDR H3s and high SHM from normal donors 40 and compared these with the four V1V2-directed bNAb lineages (Fig. 5b) . In the 
and IAVI 24 were at the edge of normal, whereas bNAbs from donors CAP256 and IAVI 84 showed more extreme values. In the SHM histograms, all antibodies were at the upper range of normal, except for PGDM1400 which was a more substantial outlier. Altogether, the lineage information from all four donors indicated that V1V2-directed bNAbs start with a long anionic CDR H3 at the recombination stage, which in a number of donors appeared to have partial recognition of N-linked glycans that evolved during maturation.
HIV-1 strains recognized by developmental intermediates
We have previously found that reversion of V1V2-directed bNAbs to UCA (or to V gene-reverted approximations) substantially restrict neutralization potency 15, 16, 20 (Fig. 6a) .
To define a common set of HIV-1-interactive isolates, we used a frequentist analysis to determine the likelihood that a particular strain might be recognized by a reverted bNAb. This analysis identified nine strains recognized by many of the reverted bNAbs (Fig. 6a) . These strains were ~10-20 times more likely than the median of the panel to be neutralized by the earliest neutralizer from each lineage (Supplementary Table 1 ). The clade B strain WITO was recognized commonly, and the clade C ZM233 strain, which we had earlier shown to be recognized by reverted versions of PG9 and CH01 (refs. 15,20) , was also commonly recognized. Direct analysis of strand-C sequences for these strains showed some differences (for example, ZM233 does not contain a glycan at residue N156 or N173, thus differentiating it from others in the group) and many commonalities, such as the presence of glycan N160 and a cationic N-terminal half of strand C (Supplementary Fig. 7) . However, we did not observe a specific distinguishing sequence characteristic separating strains neutralized by reverted bNAbs from those not neutralized. In general, the V1V2 epitope of these bNAbs involves glycan, is quaternary and is known to adopt multiple conformations. For instance, strand C, in a monomeric context, can adopt multiple conformations 41 , and the V1V2 trimeric interface on virions is conformationally dynamic 42 . Thus, the mechanism by which specific strains interact more strongly with reverted V1V2-directed bNAbs is probably both complex and multifactorial. Nonetheless, we did observe that neutralization by reverted bNAbs correlated with the neutralization potency of the mature bNAbs. One distinguishing characteristic was the high susceptibility of the select strains to being neutralized not only by the reverted bNAbs but also by the mature ones. (This susceptibility was specific to V1V2-directed antibodies because these strains were not generally sensitive to neutralization.) In general, the direct experimental assessment of strains capable of interacting with UCA or reverted bNAbs through a neutralization-based screen (such as that shown in Fig. 6 ) identifies strains from which to engineer antigens capable of binding early members of V1V2-directed bNAb lineages. The recombination frequency (0.05%) was estimated on the basis of the percentage of long (equal to or greater than 24 amino acids) and anionic (net charge of −3 or lower) CDR H3 present in 9,721 unique and productive human sequences 40 . Probability enhancements are shown for a single immunogen; substantial additional enhancement could be gained through the use of immunogen cocktails (Supplementary Table 1 npg a r t i c l e s cocktails of these strains are expected to increase the likelihood even more, and a nine-strain cocktail of all of the special strains enhances the probability of interaction by ~40-fold (Supplementary Table 1b) . A third roadblock, somatic development, through which primed B cells mature from having weak interactions with few HIV-1 strains to having strong interactions with most HIV-1 strains (Fig. 7b) , is likely to be a substantial impediment as well. Each of the bNAb lineages showed substantial maturation before the emergence of mature antibodies capable of neutralizing most HIV-1 strains (Fig. 5a) , and longitudinal data from the CAP256-VRC26 lineage have indicated years of maturation 16 . It should be possible to quantify the maturation induced by our V1V2 chimeric trimers in mouse systems comprising knockins of germline or early intermediates of the V1V2-directed antibodies, as has been done with knockins of germline or early intermediates for other bNAbs, such as those of the VRC01 class 12, 13 .
The ability of ontogeny-specific vaccine immunogens to affect specific stages of B cell development, such as that shown for the V1V2-extended class (Fig. 7c) , may be generally applicable to extended bNAb classes for which steps of UCA priming or of somatic maturation represent roadblocks to antibody development 3, 5, 7, 12, 13 . Currently, the only classes of broadly HIV-1-neutralizing antibodies that have been observed are the VH1-2-derived VRC01 class and the VH1-46-derived 8ANC131 class, both of which target the CD4 supersite 8, 10, 11 . For the VRC01 class, a severe roadblock to development involves recognition by the UCA of HIV-1 Env 5,7,10,46 . Nevertheless, neutralization by VRC01-class reverted intermediates has identified strains with characteristics known to enhance UCA recognition, such as the deletion of glycan 276 in gp120 loop D 5,10,47 ( Supplementary  Fig. 8 ). It will be exciting to see whether other classes or extended classes of bNAbs targeting HIV-1 will be identified-and whether the reversion-based neutralization strategy for ontogeny-specific vaccine design described here will be useful in their 're'-elicitation.
METHODS
Methods and any associated references are available in the online version of the paper. 
Design and validation of ontogeny-specific chimeric trimers
Although the trimeric V1V2 scaffolds that we designed and optimized for crystallization might have utility as bNAb-specific probes, their altered oligomeric presentation of V1V2 (Fig. 3) along with neoepitopes from both scaffold and exposed regions of V1V2 suggest that they might be less than optimal as vaccine immunogens. This contrasts with the correct oligomeric presentation of V1V2 in SOSIP.664 and DS-SOSIP.664 contexts 27, 32, 35 and the ability of SOSIP.664 to elicit high titers of tier 2 autologous neutralizing titers 43 . We therefore chose to use soluble DS-SOSIP.664 trimers as a platform to obtain ontogeny-specific antigens.
One issue with DS-SOSIP.664 is a difficulty in expressing strains other than BG505. To address this, we used our understanding of the V1V2 structure in the context of the prefusion closed HIV-1 Env trimer to construct V1V2 chimeras generated by swapping desired strains of HIV-1 Env into the V1V2 region of BG505 DS-SOSIP.664 trimers (Fig. 6b) . We succeeded in expressing chimeric DS-SOSIP trimers with V1V2s from all nine of the special strains that we identified by lineage reversion and HIV-1 neutralization ( Fig. 6a and Supplementary Fig. 7 ). We assessed recognition by mature and reverted bNAbs of all nine V1V2 chimeras ( Table 2 and Supplementary Fig. 7) . Binding of the reverted bNAbs to each of the nine V1V2 chimeras correlated with their neutralization of the same nine HIV-1 strains (Spearman's ρ = 0.67; P < 0.0001, one sided; n = 9 strains, 19 antibodies).
DISCUSSION
The path to creating a set of antigens capable of interacting with germline-reverted versions of V1V2-directed bNAbs involved an information flow from a supersite of vulnerability, through the definition of an extended class and the identification of specific strains capable of being neutralized by germline-reverted class members, to the engineering and antigenic validation of V1V2-chimeric trimers (Fig. 7a) . We note that for V1V2-directed bNAbs of the PG9-extended class (named after the first described antibody of the extended class), ontogeny analysis indicated three likely roadblocks to development. The first roadbock, recombination to produce a long anionic CDR H3 capable of piercing the glycan shield and backbone hydrogen-bonding to strand C of V1V2 (Fig. 7b) , is likely a substantial impediment in the development of V1V2-directed bNAbs, partly because of the rarity of long CDR H3s as a result of tolerance deletion from the naive B-cell repertoire 44 . Next-generation sequencing and CDR modeling, however, have suggested that suitable CDR H3s are present in the naive human repertoire 37 . Our ontogenybased immunogens are not expected to influence recombination frequencies and thus probably have little impact on this B cell stage.
A second roadblock that appears to be a substantial impediment is that B-cell priming requires a sufficiently strong interaction between the initial recombinant on a naive B cell and HIV-1 Env to initiate the maturation of the B-cell lineage (Fig. 7b) . For all four bNAb V1V2-directed lineages analyzed here, the UCA or gHgL could neutralize less than 5% of HIV-1 isolates (Fig. 6a) , thus suggesting that fewer than 1 in 20 HIV-1 strains can prime the naive B cells of a potential V1V2-directed bNAb lineage. In the case of the CAP256-VRC26 lineage, sequencing of coevolving antibody and virus indicates that successful priming of this lineage has occurred only because the sequence of a CAP256-SU-derived virus 45 fortuitously happened to interact with the lineage ancestor 16 . Immunization with soluble trimers with V1V2 chimeras of the special strains capable of interacting with initial recombinant, however, should substantially increase the likelihood of successful priming of the lineage. Individually, the enhancement in likelihood of interaction is ~10-20 times higher for each of the nine special strains identified here (Fig. 6a) ; 
ONLINE METHODS
Protein expression and purification. V1V2 scaffolds, codon optimized for mammalian expression, were designed with an artificial N-terminal secretion signal and a C-terminal HRV3C recognition site followed by a His 8 tag. The genes were cloned into the XbaI/BamHI sites of the mammalian expression vector pVRC8400 and transiently transfected into HEK 293S GnTI − cells (ATCC CRL-3022), which were used because of a requirement for a Man 5 GlcNAc 2 . Scaffolds were purified from the medium with Ni-NTA resin (Qiagen), and the eluted proteins were digested with HRV3C (Novagen) before passage over a 16/60 S200 sizeexclusion column.
CH03 and CH04 heavy and light chains were codon optimized for mammalian expression with an HRV3C recognition site (GLEVLFQGP) inserted after Lys235 of the heavy chain. The sequences were cloned into pVRC8400 and transiently cotransfected into Expi293 cells (Invitrogen) as previously described 22 . IgG was purified from the supernatant after 5 d with Protein A agarose (Pierce) and dialyzed into PBS.
To form homogeneous complexes, 3 mg of purified CH03 or CH04 HRV3C IgG was bound to 750 µl Protein A Plus agarose (Pierce) in a disposable 10-ml column. To this resin, 10 mg of purified V1V2 scaffold was added. Unbound scaffold was washed through the column with five column volumes of PBS. The column was capped, and 20 µl of HRV3C protease at 2 U µl −1 was added to the resin along with 1 ml of PBS. After 2 h at room temperature, the resin was drained, and the eluate was collected and passed over a 16/60 S200 column in buffer containing 5 mM HEPES, pH 7.5, 150 mM NaCl, and 0.02% NaN 3 . Fractions corresponding to the CH03-V1V2 complex were pooled and concentrated to 5 mg ml −1 .
Crystallization screening. CH03-PDB 1VH8-V1V2 SU and CH04-PDB 1VH8-V1V2 A244 were screened for crystallization with 572 conditions from Hampton, Wizard and Precipitant Synergy 48 screens with a Cartesian Honeybee crystallization robot as described previously 22 and a mosquito robot with 0.1 µl of reservoir solution and 0.1 µl of protein solution. Crystals for CH03-PDB 1VH8-V1V2 CAP256SU suitable for structural determination were obtained in 10% PEG 8000, 0.1 M CaCl, 20% MPD, and 0.1 M Na acetate, pH 5.5. Crystals were cryoprotected in a solution supplemented with 15% sucrose and flash frozen in liquid nitrogen. Crystals for CH04-PDB 1VH8-V1V2 A244 suitable for structural determination were obtained in 54% isopropanol and 0.1 M Tris, pH 8.5. Crystals were cryoprotected in a solution supplemented with 25% (2R,3R)-butane-2,3-diol and covered in paratone oil before being flash frozen in liquid nitrogen. Data were collected at a wavelength of 1.00 Å at the SER-CAT beamline ID-22 (Advanced Photon Source, Argonne National Laboratory).
X-ray data collection, structure solution and model building. Diffraction data were processed with the HKL2000 suite 49 . A molecular replacement solution for the data set consisting of three CH03 Fab molecules per asymmetric unit with the PDB 1VH8 trimer was obtained with Phenix. The CH04 complex contained two Fabs and two monomers of PDB 1VH8; the trimer conformation was maintained through crystal symmetry. Model building was carried out with COOT, and refinement was performed with Phenix. Final data collection and refinement statistics are presented in Table 1 . The Ramachandran plot as determined by MolProbity shows 91% of all residues in favored regions and 97.2% of all residues in allowed regions for the CH04 structure and 92% of all residues in favored regions and 98.4% of all residues in allowed regions for the CH04 structure. 30) ) in duplicates (30 µL/well) at a concentration of 4 µg/mL, diluted in 1× PBS; the plates were then incubated overnight at 4 °C. The following day, plates were washed (wash buffer: 0.05% Tween-20 in 1× PBS) and blocked with 150 µL of blocking buffer (5% (w/v) MSD Blocker A (MSD, cat. no. R93BA-4)) and incubated for 1 h on a vibrational shaker (Heidolph TITRAMAX 100, 544-11200-00) at 650 r.p.m. All the incubations were performed at room temperature except the coating step. During the incubation, BG505 SOSIP V1V2 chimeric trimers were titrated down in serial 2× dilutions starting at 5 µg/mL concentration of the trimer in assay diluent (1% (w/v) MSD blocker A + 0.05% . After the incubation with blocking buffer was complete, the plates were washed, and the diluted trimer was transferred (25 µl/well) to the MSD plates and incubated for 2 h on a vibrational shaker at 650 r.p.m. After the 2-h incubation with trimer, the plates were washed again, and 2G12 antibody labeled with MSD Sulfotag (MSD, cat. no. R91AN-1) at a conjugation ratio of 1:15 (2G12/Sulfotag)), which was diluted in assay diluent at 2 µg/mL, was added to the plates (25 µL/well) and incubated for 1 h on the vibrational shaker at 650 r.p.m. The plates were washed and read with the 1× read buffer (MSD Read Buffer T (4×), cat. no. R92TC-2) on an MSD Sector Imager 2400.
Antigenic analysis of BG505 SOSIP.664.DS.V1V2 by ELISA. 96-well nickelcoated plates (Thermo Fisher Scientific) were coated for 1 h at 100 µl/well with histidine-tagged BG505 SOSIP.664.DS.V1V2 constructs at 1 µg/ml, diluted in 1× PBS. The plates were then blocked at room temperature for 1 h with 200 µl/well of 5% skim milk in 1× PBS. After the plates were washed (wash buffer, 0.05% Tween 20 plus 1× PBS), they were incubated for 1 h at room temperature with five-fold serially diluted V1V2-directed antibodies at concentrations ranging from 20 to µg/ml to 1 ng/ml in 1× PBS plus 0.05% Tween 20. The plates were washed and then incubated for another hour with horseradish peroxidase (HRP)-conjugated anti-human IgG (1:5,000, Santa Cruz Biotech, sc-2543) diluted in 0.2% Tween 20 plus 1× PBS. After a final wash, the plates were then developed with TMB peroxidase substrate for 20 min. The reaction was stopped with 140 mM HCl, and then the absorbance was measured at 450 nm. All incubations were at 100 µl/well at room temperature, except where noted otherwise. Experiments were run in triplicate.
Neutralization panels. Single-round-replication Env pseudoviruses were prepared, titered and used to infect TZM-bl target cells as described previously 59, 60 . The data were calculated as a reduction in luminescence units compared with that in control wells, and neutralization curves were fit by nonlinear regression with a five-parameter Hill slope equation. Data are reported as 50% inhibitory concentration (IC 50 ) in micrograms per microliter. Neutralization was assayed with a previously described panel 6 of 200 geographically and genetically diverse Env-pseudoviruses representing the major subtypes and circulating recombinant forms.
Negative-stain electron microscopy. Negative-stain EM samples were diluted to ~0.03 mg/ml, adsorbed to a freshly glow-discharged carbon-film grid for 15 s, and stained with 0.7% uranyl formate. Images were collected semiautomatically with SerialEM 61 on an FEI Tecnai T20 with a 2k × 2k Eagle CCD camera at a pixel size of 0.22 nm/pixel. Particles were picked automatically, and reference-free 2D classification was performed in EMAN2 (ref. 62).
Hydrogen-deuterium exchange (HDX).
To identify Env-interactive residues within CAP256-VRC26.03, rates of hydrogen-deuterium exchange for CAP256-VRC26.03 Fab alone and in the presence of BG505 SOSIP.664 (2:1 molar ratio, Fab/SOSIP (a ratio for which 50% of CAP256-VRC26.03 Fab and 100% of SOSIP should be bound) were measured. Deuteration reactions were initiated by diluting 10 µL of 0.56 mg/mL CAP256-VRC26.03 Fab (± SOSIP) into 90 µL of phosphate buffered saline containing 85% D 2 O. Deuterations were carried out for 10 s, 12 s, and 60 s before the addition of 90 µL of quenching solution (500 mM Tris-2-carboxyethyl phosphine (TCEP), 3 M urea, and 0.2% formic acid, with a final pH of 2.5), 10 µL pepsin (2 mg/mL in 100 mM phosphate, pH 4.0) and digestion on ice for 5 min. Pepsin-digested HDX samples were plunge frozen in liquid nitrogen and stored at −80 °C. Ligand-free and SOSIP-bound VRC26.03 HDX samples were prepared side by side in matched buffers. For LC-MS analysis, samples were thawed on ice for 5 min and manually injected onto a Waters BEH 1.7-µm, 1.2 × 5 mm trap column (Waters) flowing 0.1% TFA at 200 µL/min. After 3 min of washing, the peptides were resolved over a Hypersil 1 × 50 mm, 2.1-µm C18 column (Thermo Scientific) with a gradient of 15% to 40% B in 8 min (A, 0.05% TFA and 5% ACN; B, 0.05% TFA and 80% ACN). Eluted peptides were analyzed in duplicate with a Waters Synapt Q-TOF mass spectrometer. Peptide identification and exchange analysis were as described previously 63 , with the exception that percentage deuteration was calculated with the number of exchangeable backbone amides to estimate theoretical 100% deuteration for each peptide.
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In silico arginine scanning.
Step one of our in silico arginine-scanning method involved mutating each residue in the CDR region to arginine. Any endogenous arginine or lysine residues were left unmutated but were still used in all subsequent analyses. To carry out all of our in silico mutations, we used the side chain modeling program Scap 64 with default settings.
Step two of our method scored and determined the solvent accessibility of each predicted arginine residue. To assess the feasibility of adopting an arginine at a particular position in a CDR region, each mutated residue was scored independently with a modified RAPDF distance-dependent statistical potential 40 . The scores for each residue were computed as follows: ∆E i = RAPDF i (ARG) − RAPDF i (NAT), where the subscript i denotes the residue position, and ARG and NAT denote the scores of the mutated and native residue, respectively. We used the Surface 65 program to determine the solvent-accessible surface area (SASA) of each residue. The SASA was normalized to a reference SASA for the same residue, as determined from a linear peptide composed of three residues in extended conformation with glycine as the first and last residue. The normalized SASA was computed as follows: Acc i = SASA i (S)/SASA i , where S denotes the side chain in the protein environment, and L denotes the side chain in the linear peptide environment. The normalization factor allowed for an unbiased comparison of solvent accessibility for residues of different amino acid types (and sizes). A weighting factor (set to 1.0) was used to convert the normalized SASA value into a score. The final step of our method involved a stochastic search for the optimal set of arginine residues, on the basis of the RAPDF and solvent-accessibility scores determined in step two. Each cycle of the search began by random selection of a seed residue from the set of CDR residues. All residues within a 5.0-Å radius of the seed residue were removed ('flagged') from the set of selectable residues in the current cycle. We next determined the closest residue greater than 5.0 Å (measured from the Cα atom) away from the current seed residue. This residue was then set as the seed residue, and all residues within a 5.0-Å radius were removed from the set of selectable residues. The process was repeated until all residues had been selected. At the end of each cycle, the total score for the final set of seed residues was determined from the look-up tables generated in step two. The total score was computed as follows: F = Σ i = 1,N (∆E i − Acc i ), where ∆E i is the RAPDF-based score, and Acc i is the weighted normalized SASA score. The stochastic search continued until the lowest F score no longer changed, or the user-specified maximum number of cycles (set to 1,000) had been reached. The set of residues with the lowest F score was selected as the optimal set of residues to mutate to arginine.
Phylogenetic analysis involving donors CH0219, CAP256, IAVI24 and IAVI84 and CAP256. Donor CH0219. Pan-B cells were isolated from Donor 0219 PBMC (Miltenyi Biotec) and processed as reported previously for paired heavy-and lightchain sequencing 16 . All 454 and Illumina NGS heavy-chain sequences were processed with an in-house version of IgBlast 66 and then filtered on the basis of their heavy-chain V and J germline gene assignments. All sequences with the IgVH 3-20 and IgJH 2 germline gene assignments were retained for further processing. To enrich the pool of transcripts with long CDR H3s, we filtered out any sequences with CDR H3 lengths (Kabat) less than 24 amino acids. Duplicated sequences were removed, and problematic sequences were edited to bring the transcript into the correct translational frame. A multiple sequence alignment for the final set of sequences was generated with CLUSTAL0 (ref. 67 ) with default settings, and this was followed by manual inspection. A maximum-likelihood (ML) tree was constructed with the program dnaml, which is part of the PHYLIP package v3.69 (http://evolution.genetics.washington.edu/phylip.html). The 'S' option was set to 'No' to provide a more thorough optimization. The inferred intermediates were derived from the ML tree. Nucleotide sequences for CH01-CH04 were downloaded from GenBank (JQ267523.1-JQ267526.1).
Donor CAP256. The ML tree was obtained from a study by Doria-Rose et al. 16 . The nucleotide sequence for the CAP256-VRC26.UCA was downloaded from GenBank (KJ134860.1).
Donor IAVI24. nucleotide sequences for PG9 (GenBank GU272045.1) and PG16 (GenBank GU272043.1) were aligned, and the alignment was used to generate an ML tree with dnaml with the same procedure as for donor CH0219. The inferred intermediate was derived from the ML tree. Donor IAVI84. 454 NGS sequences were downloaded from the SRA (SRP018335) and processed in the same manner as for donor CH0219. Sequences were then filtered according to their V germline gene assignments. All sequences with the IgVH1-8 germline gene assignment were retained for further processing with intradonor phylogenetic analysis. The major objective of intradonor phylogenetic analysis is to bracket all phylogenetically similar sequences on a neighbor-joining (NJ) tree with known neutralizingantibody sequences derived from the same donor. For the analysis here, we used all possible pairs of neutralizing-antibody sequences derived from this donor PGDM1400-1412 (GenBank KP006370-KP006382) and PGT141-145 (GenBank JN201906.1-JN201910.1).
Intradonor phylogenetic analysis works in similar fashion to the cross-donor phylogenetic analysis described previously 11 . Briefly, the method begins by randomly shuffling all the sequences in a data set to remove any potential bias in the order of the sequences and to improve the convergence of the method. After sequence shuffling, the data set was split into FASTA files, each containing up to 5,000 sequences. A pair of neutralizing-antibody sequences along with the germline VH gene sequence was added to each FASTA file. The germline gene sequence was used as the outgroup in the NJ tree. A multiple sequence alignment for each FASTA file was generated with CLUSTAL0 (ref. 67 ), and each alignment was then converted into a distance matrix with dnadist (with default settings). From this matrix, an NJ tree was constructed with the 'neighbor' program (with default settings). Both dnadist and neighbor are part of the PHYLIP package. Donor sequences were extracted from each NJ tree with a pair of neutralizingantibody sequences derived from the same donor. All donor sequences contained in the minimal-spanning tree containing the pair of neutralizing sequences were extracted from the NJ tree and split into FASTA files containing no more than 5,000 sequences, and the above process was repeated five times. The remaining sequences were filtered by their germline J gene retaining all sequences with the IgJH 6 assignment. We filtered out any transcripts with CDR H3 lengths (Kabat) less than 31 amino acids and greater than 34 amino acids. Duplicate sequences were removed, and problematic sequences were edited to bring the transcript into the correct translational frame. The remaining sequences were aligned and then used to generate an ML tree with dnaml, with the same procedure as for donor CH0219. The inferred intermediates were derived from the ML tree.
Modeling the CAP256-VRC26.9 and the HIV-1 Env trimer complex. A combination of molecular dynamics (MD) and molecular dynamics flexible-fitting (MDFF) simulations were used to model the complex consisting of the prefusion HIV-1 Env trimer and CAP256-VRC26.09 antibody. First, any loop regions on the HIV-1 Env prefusion trimer were modeled in Loopy 68 . We then added mannose 5 to each sequon position. A model for the CAP256-VRC26.09 antibody was obtained by threading the amino acid sequence of CAP256-VRC26.09 onto the CAP256.VRC26.03 antibody structure (PDB 4OD1) with Nest 65 . Models for the trimer and antibody were docked as rigid bodies into the cryo-EM map (EMD 5856) with Colores in the SITUS package 69 . The complex was then solvated in a 15-Å water box and neutralized by the addition of NaCl at a concentration of 150 mM.
After rigid-body docking into the cryo-EM map, we applied a combination of MDFF and MD to the complex, then MD alone to relax the complex. The simulation was performed with NAMD 70 , using the CHARMM36 force field, including CMAP corrections for the protein. TIP3P water parameterization was used to model the solvent. Periodic electrostatic interactions were computed with particlemesh Ewald (PME) summation with a grid spacing smaller than 1 Å. Constant temperature was imposed with Langevin dynamics with a damping coefficient of 1.0 ps. A constant pressure of 1 atmosphere was maintained with Langevin piston dynamics, a 200-fs decay period and a 50-fs time constant. During equilibration, the trimer's secondary structure was restrained with harmonic restraints applied to the backbone's torsional angles and interacting strands (strand C on the trimer and the strand on CDR H3). The system was minimized using 5,000 steps of conjugate gradient minimization and then equilibrated with a linear temperature gradient, which heated up the system from 0 to 310 K in 5 ns. An additional 5 ns of simulation was carried out, and this was followed by 5 ns MDFF. The protein secondary structure, the chirality and the interacting strains were restrained. The system was relaxed during 20 ns and then subjected to a second 5-ns MDFF run in which the interacting strains were not restrained. Finally, unrestrained molecular dynamics was performed up to 50 ns. The lengths of all bonds involving hydrogen atoms was constrained with the RATTLE algorithm, thus allowing a time step of 2 fs.
Figures. Structure figures were prepared with PyMOL ((http://www.pymol.org/). Figure 6a was generated with GraphPad Prism (http://www.graphpad.com/ scientific-software/prism/). EM-structure images were generated with Chimera (http://www.cgl.ucsf.edu/chimera/). Phylogenetic trees were generated with Dendroscope (http://ab.inf.uni-tuebingen.de/software/dendroscope/).
